Recently, the anti-aging instrument Peninsula ultrasonic gun is quite popular in the medical and American market, once catching up with the previous hot Maggie. In an interview with the financial Associated Press, many people in the medical and American industry said they were optimistic about the future market prospect of peninsula ultrasonic gun and the domestic alternative space in the field of medical and American equipment and instruments.
In an interview with the financial Associated Press, a medical beauty analyst said: “the good view of the ultrasonic gun is mainly based on the certificate of the ultrasonic gun, and the compliance of the medical beauty industry is the basis.” The reporter learned that medical equipment and instruments have a long certification cycle and strict approval. At present, peninsula ultrasonic gun is one of the few domestic medical equipment and instruments approved by nmpa in the market; Behind the brand is Shenzhen Peninsula Medical Company.
A medical and American related person told the financial associated press that under the influence of the epidemic, the import cycle of foreign instruments and equipment is lengthened, and the ultrasonic gun is expected to take advantage of the situation to realize domestic replacement, and in contrast, the cost performance of peninsula ultrasonic gun is higher. AI media research data show that in 2019, imported equipment by legal institutions accounted for 80% of the market share, while domestic equipment accounted for only 9%.
(Note: the equipment of Chinese medical and American institutions in 2019 comes from AI media data center, Meibai medical health, etc.)
In addition, the above medical beauty analysts said that in terms of brand awareness, light medical beauty consumers have a certain awareness of the brand of injection products, and photoelectric projects are still in the stage of identifying the project itself rather than the equipment brand. Therefore, domestic substitution has a large space in the field of equipment.
Indeed, under the epidemic situation, China’s medical and American equipment and instrument market has increased greatly, and the gross profit margin has further improved. Taking Qizhi laser (832861. OC) as an example, in the first half of 2021, the company’s beauty equipment achieved a revenue of 85.5354 million yuan, a year-on-year increase of 160.20%; The corresponding gross profit margin was 61.01%, with a year-on-year increase of 6.27%.
Since the development of China’s related beauty technology started later than that of European and American developed countries, in the early stage of market startup, foreign-funded enterprises occupied most of the market of China’s public and medium and high-end private hospitals relying on strong brand and technical advantages. Statistics show that China’s medical and American instrument and equipment market is mainly divided by Israeli brand Syneron, American brand cynosure, lumennis, zeltiq aesthetics, cutera, Venus concept and other international brands.
In terms of breakdown, at present, medical and American equipment and instruments mainly include three technical types: light wave, electromagnetic wave and acoustic wave. Among them, the representative technologies and projects of light wave include LED red and blue light project (with low technical content), pulsed light photon rejuvenation project (on behalf of enterprise scientists and doctors), excitation lattice laser project, laser speckle removal project and picosecond laser project (Sano show); Electromagnetic wave is mainly RF thermal Maggie project and thermal lati project (on behalf of the enterprise feidun, Shanghai Fosun Pharmaceutical (Group) Co.Ltd(600196) ); Acoustic wave is mainly the anti-aging and skin texture improvement and wrinkle removal project of ultrasonic knife (representative enterprise ultrara).
At present, the representative enterprises in the field of domestic medical and American equipment and instruments include Shanghai Fosun Pharmaceutical (Group) Co.Ltd(600196) (600196. SH), Huadong Medicine Co.Ltd(000963) (000963. SZ), Shanghai Haohai Biological Technology Co.Ltd(688366) (688366. SH) and Qizhi laser. In recent years, there has been a wave of acquisitions in this field, Shanghai Fosun Pharmaceutical (Group) Co.Ltd(600196) acquired sisram, an Israeli medical and American equipment manufacturer, Huadong Medicine Co.Ltd(000963) acquired Sinclair in the UK and high tech in Spain, Shanghai Haohai Biological Technology Co.Ltd(688366) acquired ouhuameike, etc.
(Note: net interest rate of each link of the medical and American industry chain (%), from Citic Securities Company Limited(600030) )
According to the data, cooltech define, a non-invasive frozen fat dissolving equipment independently developed by Huadong Medicine Co.Ltd(000963) high tech, has officially obtained EU CE certification in February 2021. Titania, an innovative RF product under research for skin tightening and body shaping, is expected to obtain EU CE certification in the fourth quarter of 2021 and will be listed and sold worldwide after approval.
However, on the whole, the overall net interest rate in the field of medical equipment and instruments is low. According to Citic Securities Company Limited(600030) data, the gross profit margin of international manufacturers such as sanuoxiu and sanuolong is about 50% – 70%, the net profit margin is only about 0.1% – 3.3%, and the corresponding net profit margin of dealers is 8%.
(Financial Associated Press)
